An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression
- PMID: 20478527
- PMCID: PMC2874722
- DOI: 10.1016/j.ccr.2010.03.018
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression
Abstract
Chromosomal rearrangements fusing the androgen-regulated gene TMPRSS2 to the oncogenic ETS transcription factor ERG occur in approximately 50% of prostate cancers, but how the fusion products regulate prostate cancer remains unclear. Using chromatin immunoprecipitation coupled with massively parallel sequencing, we found that ERG disrupts androgen receptor (AR) signaling by inhibiting AR expression, binding to and inhibiting AR activity at gene-specific loci, and inducing repressive epigenetic programs via direct activation of the H3K27 methyltransferase EZH2, a Polycomb group protein. These findings provide a working model in which TMPRSS2-ERG plays a critical role in cancer progression by disrupting lineage-specific differentiation of the prostate and potentiating the EZH2-mediated dedifferentiation program.
(c) 2010 Elsevier Inc. All rights reserved.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2874722/bin/nihms195231f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2874722/bin/nihms195231f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2874722/bin/nihms195231f3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2874722/bin/nihms195231f4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2874722/bin/nihms195231f5.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2874722/bin/nihms195231f6.gif)
![Figure 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2874722/bin/nihms195231f7.gif)
Comment in
-
Coordinate transcriptional regulation by ERG and androgen receptor in fusion-positive prostate cancers.Cancer Cell. 2010 May 18;17(5):415-6. doi: 10.1016/j.ccr.2010.04.022. Cancer Cell. 2010. PMID: 20478521 Free PMC article.
Similar articles
-
Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis.Mol Cell. 2018 Aug 16;71(4):554-566.e7. doi: 10.1016/j.molcel.2018.06.040. Epub 2018 Aug 2. Mol Cell. 2018. PMID: 30078722 Free PMC article.
-
Relation of ETS transcription factor family member ERG, androgen receptor and topoisomerase 2β expression to TMPRSS2-ERG fusion status in prostate cancer.Neoplasma. 2014;61(1):9-16. Neoplasma. 2014. PMID: 24195515
-
Emerging biological observations in prostate cancer.Expert Rev Anticancer Ther. 2010 Jan;10(1):89-101. doi: 10.1586/era.09.161. Expert Rev Anticancer Ther. 2010. PMID: 20014889 Review.
-
[Molecular aspects of prostate cancer: recent data from the literature].Bull Cancer. 2007 Jul;94(7 Suppl):F77-88. Bull Cancer. 2007. PMID: 17845997 Review. French.
-
TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.Cancer Res. 2006 Nov 15;66(22):10658-63. doi: 10.1158/0008-5472.CAN-06-1871. Cancer Res. 2006. PMID: 17108102
Cited by
-
Advances in sequencing and omics studies in prostate cancer: unveiling molecular pathogenesis and clinical applications.Front Oncol. 2024 May 10;14:1355551. doi: 10.3389/fonc.2024.1355551. eCollection 2024. Front Oncol. 2024. PMID: 38800374 Free PMC article.
-
IFDlong: an isoform and fusion detector for accurate annotation and quantification of long-read RNA-seq data.bioRxiv [Preprint]. 2024 May 14:2024.05.11.593690. doi: 10.1101/2024.05.11.593690. bioRxiv. 2024. PMID: 38798496 Free PMC article. Preprint.
-
ERG activates a stem-like proliferation-differentiation program in prostate epithelial cells with mixed basal-luminal identity.bioRxiv [Preprint]. 2024 Apr 6:2023.05.15.540839. doi: 10.1101/2023.05.15.540839. bioRxiv. 2024. PMID: 38585869 Free PMC article. Preprint.
-
Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer.Genome Med. 2024 Apr 2;16(1):52. doi: 10.1186/s13073-024-01323-6. Genome Med. 2024. PMID: 38566104 Free PMC article. Review.
-
Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancer.Sci Rep. 2024 Mar 25;14(1):7082. doi: 10.1038/s41598-024-57854-w. Sci Rep. 2024. PMID: 38528115 Free PMC article.
References
-
- Anderson J. The role of antiandrogen monotherapy in the treatment of prostate cancer. BJU international. 2003;91:455��461. - PubMed
-
- Bailey TL, Elkan C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proceedings/International Conference on Intelligent Systems for Molecular Biology ; ISMB. 1994;2:28–36. - PubMed
-
- Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. High-resolution profiling of histone methylations in the human genome. Cell. 2007;129:823–837. - PubMed
-
- Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, Levine SS, Wernig M, Tajonar A, Ray MK, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature. 2006;441:349–353. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
- K99CA129565-01A1/CA/NCI NIH HHS/United States
- U01 111275/PHS HHS/United States
- K99 CA129565-02/CA/NCI NIH HHS/United States
- K99 CA129565-02S1/CA/NCI NIH HHS/United States
- K99 CA129565/CA/NCI NIH HHS/United States
- P50 CA069568/CA/NCI NIH HHS/United States
- U01 CA111275/CA/NCI NIH HHS/United States
- P50CA090386/CA/NCI NIH HHS/United States
- R01 CA132874-01A1/CA/NCI NIH HHS/United States
- P50 CA069568-110020/CA/NCI NIH HHS/United States
- P50 CA069568-06A10016/CA/NCI NIH HHS/United States
- 1R01HG005119/HG/NHGRI NIH HHS/United States
- R01 CA132874/CA/NCI NIH HHS/United States
- U01 CA111275-01/CA/NCI NIH HHS/United States
- 1R01CA132874-01A1/CA/NCI NIH HHS/United States
- HHMI/Howard Hughes Medical Institute/United States
- P50CA69568/CA/NCI NIH HHS/United States
- P50 CA069568-06A19001/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials